The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- 8 August 2006
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 155 (4) , 852-854
- https://doi.org/10.1111/j.1365-2133.2006.07452.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximabBritish Journal of Dermatology, 2005
- Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitorsAnnals of Oncology, 2005
- Cutaneous Adverse Effects With HER1/EGFR-Targeted Agents: Is There a Silver Lining?Journal of Clinical Oncology, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Clinical heterogeneity of drug hypersensitivityToxicology, 2005
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptorBritish Journal of Dermatology, 2002
- Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor InhibitionJournal of Clinical Oncology, 2002
- Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor InhibitionJournal of Clinical Oncology, 2002
- Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225British Journal of Dermatology, 2001
- Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.The EMBO Journal, 1995